ABACAVIR SO4 60MG/DOLUTEGRAVIR 5MG/LAMIVUDINE 30MG TAB,SUSP,ORAL (31890) VA PRODUCT (50.68)

Name	Value
NAME	ABACAVIR SO4 60MG/DOLUTEGRAVIR 5MG/LAMIVUDINE 30MG TAB,SUSP,ORAL
VA GENERIC NAME	ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE
DOSAGE FORM	TAB,SUSP,ORAL
FDA MED GUIDE	Abacavir-Dolutegravir-Lamivudine_(Triumeq)_(Oct_2022).pdf
HAZARDOUS TO DISPOSE	NO
FORMULARY DESIGNATOR TEXT
ACTIVE INGREDIENTS	LAMIVUDINE STRENGTH: 30 UNITS: MG ABACAVIR SULFATE STRENGTH: 60 UNITS: MG DOLUTEGRAVIR STRENGTH: 5 UNITS: MG
CS FEDERAL SCHEDULE	Unscheduled
SINGLE/MULTI SOURCE PRODUCT	Multisource
NATIONAL FORMULARY NAME	ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE TAB,SUSP,ORAL
CREATE DEFAULT POSSIBLE DOSAGE	YES
CODING SYSTEM	RxNorm CODE:
COPAY TIER	COPAY TIER LEVEL: 3 COPAY EFFECTIVE DATE: 2022-04-14 00:00:00
PGX ELIGIBLE	YES
PGX SUPPRESSED	NO
VA PRINT NAME	TRIUMEQ PD 60/5/30MG SUSP TAB ORAL
VA PRODUCT IDENTIFIER	T1108
TRANSMIT TO CMOP	NO
VA DISPENSE UNIT	TAB
MASTER ENTRY FOR VUID	YES
VUID	4041337
EFFECTIVE DATE/TIME	2022-04-14 00:00:00 STATUS: ACTIVE